Dynamical questions in volume transmission

References

• N. Abudukeyoumu, T. Hernandez-Flores, M. Garcia-Munoz, and G. Arbuthnott, Cholinergic modulation of striatal microcircuits, Eur. J. Neurosci. 49 (2019), pp. 604–622.
   PubMed Web of Science ®Google Scholar
• A. Adell, P. Celada, M.T. Abella, and F. Artigasa, Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei, Brain Res. Rev. 39 (2002), pp. 154–180.
   PubMedGoogle Scholar
• Y. Agid, Parkinson's disease: pathophysiology, Lancet 337 (1991), pp. 1321–1324.
   PubMedGoogle Scholar
• E. Benarroch, Effects of acetylcholine in the striatum, Neurology 79 (2012), pp. 274–281.
   PubMed Web of Science ®Google Scholar
• B. Bergstrom and P. Garris, ‘Passive stabilization’ of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat, J. Neurochem. 87 (2003), pp. 1224–1236.
   PubMed Web of Science ®Google Scholar
• H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K.K. Jellinger, and F. Seitelberger, Brain dopamine and the syndromes of Parkinson and Huntington, J. Neurol. Sci. 20 (1973),pp. 415–455.
   PubMed Web of Science ®Google Scholar
• J. Best, W. Duncan, F. Sadre-Marandi, P. Hashemi, H.F. Nijhout, and M. Reed, Autoreceptor control of serotonin dynamics, BMC Neurosci. 21 (2020), p. 40.
   PubMed Web of Science ®Google Scholar
• J.A. Best, H.F. Nijhout, and M.C. Reed, Homeostatic mechanisms in dopamine synthesis and release: a mathematical model, Theor. Biol. Med. Model. 6 (2009), p. 21.
   PubMed Web of Science ®Google Scholar
• J. Best, H.F. Nijhout, S. Samaranayake, P. Hashemi, and M. Reed, A mathematical model for histamine synthesis, release, and control in varicosities, Theor. Biol. Med. Model. 14 (2017),p. 24.
   PubMed Web of Science ®Google Scholar
• E. Bezard, S. Dovero, C. Prunier, P. Ravenscroft, S. Chalon, D. Guilloteau, A.R. Crossman, B.Bioulac, J.M. Brotchie, and C.E. Gross, Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine-lesioned macaque model of Parkinson's disease, J. Neurosci. 21 (2001), pp. 6853–6861.
   PubMed Web of Science ®Google Scholar
• P. Blandina, J. Goldfarb, B. Craddock-Royal, and J. Green, Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in the rat striaum, J. Phamacol. Exp. Ther. 251 (1989), pp. 803–809.
   PubMed Web of Science ®Google Scholar
• N. Bonhomme, P. Duerwaerdere, M. Moal, and U. Spampinato, Evidence for 5-ht4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat, Neuropharmacology 34 (1995),pp. 269–279.
   PubMed Web of Science ®Google Scholar
• V. Booth and C. Dehn, Physiologically-based modeling of sleep-wake regulatory networks, Math. Biosci. 250 (2014), pp. 54–68.
   PubMed Web of Science ®Google Scholar
• C. Dentresangle, M.L. Cavorison, M. Savasta, and V. Leviel, Increased extracellular da and normal evoked da release in the rat striatum after a partial lesion of the substantia nigra, Brain. Res. 893 (2001), pp. 178–185.
   PubMed Web of Science ®Google Scholar
• K. Eriksson, D. Stevens, and H. Haas, Serotonin excites tuberomammillary neurons by activation of na+/ca2+-exchange, Neuropharmacology 40 (2001), pp. 345–351.
   PubMed Web of Science ®Google Scholar
• J. Fearnley and A. Lees, Ageing and Parkinson's disease: substantia nigra regional selectivity, Brain A J. Neurol. 114 (1991), pp. 2283–2301.
   Google Scholar
• R. Feldman, J. Meyer, and L. Quenzer, Principles of Neuropharmacology, Sinauer Associates, Inc., Sunderland, MA, 1997.
   Google Scholar
• C. Flores-Clemente, M. Nicolás-Vázquez, E. Jimènez, and M. Hernàndez-Rodrìguez, Inhibition of astrocytic histamine n-methyltransferase as a possible target for the treatment of Alzheimer's disease, Biomolecules 11 (2021), p. 1408.
   PubMed Web of Science ®Google Scholar
• K. Fuxe, A.B. Dahlstrom, G. Jonsson, D. Marcellino, M. Guescini, M. Dam, P. Manger, and L.Agnati, The discovery of central monoamine neurons gave volume transmission to the wired brain, Prog. Neurobiol. 90 (2010), pp. 82–100.
   PubMed Web of Science ®Google Scholar
• A. Girasole and A. Nelson, Probing striatal microcircuitry to understand the functional role of cholinergic interneurons, Mov. Disord. 30 (2015), pp. 1306–1318.
   PubMed Web of Science ®Google Scholar
• A. Granger, M. Wallace, and B. Sabatini, Multi-transmitter neurons in the mammalian central nervous system, Curr. Opin. Neurobiol. 45 (2017), pp. 85–91.
   PubMedGoogle Scholar
• P. Hashemi, Personal communication.
   Google Scholar
• T. Hnasko and R. Edwards, Neurotransmitter corelease: mechanism and physiological role, Annu. Rev. Physiol. 74 (2012), pp. 225–243.
   PubMed Web of Science ®Google Scholar
• Z. Huszti, K. Magyar, and M. Kalman, Contribution of glial cells to histamine inactivation, Agents Actions 30 (1990), pp. 237–239.
   PubMedGoogle Scholar
• S. Kish, K. Shannak, and O. Hornykiewicz, Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications, N. Engl. J. Med. 318 (1988), pp. 876–880.
   PubMed Web of Science ®Google Scholar
• C. Lacey, J. Boyes, O. Gerlach, L. Chen, P. Magill, and J. Bolam, Gabab receptors at glutamatergic synapses in the rat striatum, Neuroscience 136 (2005), pp. 1083–1095.
   PubMed Web of Science ®Google Scholar
• K. Laitinen, L. Tuomisto, and J. Laitinen, Endogenous serotonin modulates histamine release in the rat hypothalamus as measured by in vivo microdialysis, Eur. J. Pharmacol. 285 (1995),pp. 159–164.
   PubMed Web of Science ®Google Scholar
• J.M. Monti, The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness, Sleep Med. Rev. 14 (2010), pp. 307–317.
   PubMed Web of Science ®Google Scholar
• R. Oishi, Y. Itoh, and K. Saeki, Inhibition of histamine turnover by 8-oh-dpat, buspirone and 5-hydroxytryptophan in the mouse and rat brain, Arch. Pharma 345 (1992), pp. 495–499.
   Google Scholar
• B. Pakkenberg, A. Moller, H. Gundersen, A. Dam, and H. Pakkenberg, The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method, J. Neurol. Neurosurg. Psychiatry 54 (1991),pp. 30–33.
   PubMed Web of Science ®Google Scholar
• R. Phillips, I. Rosner, A. Gittis, and J. Rubin, The effects of chloride dynamics on substantia nigra pars reticulata responses to pallidal and striatal inputs, Elife 9 (2020), p. e55592.
   PubMed Web of Science ®Google Scholar
• H. Prast, M. Tran, H. Fisher, M. Kraus, C. Lamberti, K. Grass, and A. Philippu, Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors, Arch. Pharma 360 (1999), pp. 558–564.
   Google Scholar
• H. Prast, M. Tran, C. Lamberti, H. Fischer, M. Kraus, K. Grass, and A. Philippu, Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H1 and H2 histamine receptors, Arch. Pharma 360 (1999), pp. 552–557.
   Google Scholar
• M. Reed, J. Best, and H.F. Nijhout, Passive and active stabilization of dopamine in the striatum, Biosci. Hypotheses. 2 (2009), pp. 240–244.
   Google Scholar
• P. Riederer and S. Wuketich, Time course of nigrostriatal degeneration in Parkinson's disease, J. Neural. Transm. 38 (1976), pp. 277–301.
   PubMed Web of Science ®Google Scholar
• B. Roberts, E. Lopes, and S. Cragg, Axonal modulation of striatal dopamine release by local gaba signalling, Cells 10 (2021), p. 709.
   PubMed Web of Science ®Google Scholar
• S. Samaryake, A. Abdalla, R. Robke, H.F. Nijhout, M. Reed, J. Best, and P. Hashemi, A voltammetric and mathematical analysis of histaminergic modulation of serotonin in the mouse hypothalamus, J. Neurochem. 138 (2016), pp. 372–383.
   Web of Science ®Google Scholar
• D. Scherman, C. Desnos, F. Darchen, P. Pollak, F. Javoy-Agid, and Y. Agid, Striatal dopamine deficiency in Parkinson's disease: role of aging striatal dopamine deficiency in Parkinson's disease: role of aging striatal dopamine deficiency in Parkinson's disease: role of aging, Ann. Neurol. 26 (1989), p. 551–557.
   PubMed Web of Science ®Google Scholar
• E. Svensson, J. Apergis-Schoute, G. Burnstock, M. Nusbaum, D. Parker, and H. Schioth, General principles of neuronal co-transmission: insights from multiple model systems, Front. Neural Circuits12 (2019), p. 117.
   PubMed Web of Science ®Google Scholar
• T. Yoshikawa, T. Nakamura, and K. Yanai, Histamine n-methyltransferase in the brain, Int. J. Mol. Sci. 20 (2019), p. 737.
   PubMed Web of Science ®Google Scholar
• M. Zygmond, E. Abercrombie, T. Berger, A. Grace, and E. Stricker, Compensation after lesions of central dopaminergic neurons: some clinical and basic implications, Trends Neurosci. 13 (1990), pp. 290–296.
   PubMed Web of Science ®Google Scholar